Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Literature
1.
Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179:146–60.CrossRefPubMedPubMedCentral
2.
Datta R, Kuruvilla M, Gill M, de la Morena MT. Association of skin necrosis with subcutaneous immunoglobulin therapy. Ann Allergy Asthma Immunol. 2014;113:232–3.CrossRefPubMed
3.
Ponsford M, Carne E, Kingdon C, Joyce C, Price C, Williams C, et al. Facilitated subcutaneous immunoglobulin (fSCIg) therapy—practical considerations. Clin Exp Immunol. 2015;182:302–13.CrossRefPubMedPubMedCentral
4.
Jain S, Pandey K, Lahoti A, Rao P. Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin naive, type-2 diabetic adult population. Indian J Endocrinol Metab. 2013;17:864–70.CrossRefPubMedPubMedCentral
5.
Kang DW, Jadin L, Nekoroski T, Drake FH, Zepeda ML. Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model. Drug Deliv Transl Res. 2012;2:254–64.CrossRefPubMed
Metadata
Title
Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg)
Authors
Emily Carne
Mark Ponsford
Tariq El-Shanawany
Stephen Jolles
Publication date
01-01-2017
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2017
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0346-6

Other articles of this Issue 1/2017

Journal of Clinical Immunology 1/2017 Go to the issue

Letter to Editor

Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection

Original Article

Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study

Original Article

Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients

Letter to Editor

Comments on J Clin Immunol (2014) 34:633–641 DOI 10.1007/s10875-014-0061-0

Letter to Editor

OL-EDA-ID Syndrome: a Novel Hypomorphic NEMO Mutation Associated with a Severe Clinical Presentation and Transient HLH

Original Article

A CD57+ CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits